Skip to content

Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars

Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07263100
Enrollment
20
Registered
2025-12-04
Start date
2023-05-01
Completion date
2024-01-31
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Scar, Keloid, Laser

Keywords

Hypertrophic scar, Keloid, Laser

Brief summary

To compare the effectiveness of hypertrophic or keloid scar treatment with either intralesional corticosteroid injection alone or combined intralesional corticosteroid injection with either long-pulse ND YAG or Erbium YAG

Interventions

Long-pulse ND YAG and Erbium YAG laser device: Fotona Dynamis

DEVICEFotona dynamis: Long pulse Nd YAG + Er YAG laser

Intralesional corticosteroid injection combine with long-pulse Neodynium-doped Yttrium Aluminium Garnet Laser (Nd-YAG) (IL KA + ND YAG)

DEVICEFotona Dynamis: Long pulse Nd YAG + Er YAG laser

Intralesional corticosteroid injection combine with Erbium Yttrium Aluminium Garnet Laser (Er-YAG) (IL KA + Er YAG)

Sponsors

Somdech Phra Nangchao Sirikit Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individual with hypertrophic or keloid scars on any location * Size of hypertrophic or keloid scars not larger than 20 cms in diameter

Exclusion criteria

* Any topical or procedural treatment on scar in last 6 months * Current corticosteroid use * Bleeding disorders or coagulopathies * Pregnancy or nursing * Chronic kidney diseases * Chronic liver diseases

Design outcomes

Primary

MeasureTime frameDescription
Vancouver scar scale5 monthsVancouver scar scale to evaluate scar severity of keloid scar assessing 4 variations including vascularity, pigmentation, pliability, height scoring range from 0-13 (the more scores resembling the more severity)

Secondary

MeasureTime frameDescription
Japan Scar Workshop Scar Scale5 monthsJapan Scar Workshop Scar Scale to evaluate scar severity of keloid scar assessing 2 main domains (risk factors and presenting symptoms) by 2 tables 1. Classification scoring range 0-5 = matured scars 6-15 = hypertrophic scars 16-25 = keloids 2. Evaluation for treatment & follow ups scoring range from 0-18 (the more scores resembling the more severity)

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026